Our M&A Due Diligence service provides comprehensive commercial, technical, and regulatory due diligence for pharmaceutical and biotech acquisitions. We combine AI-powered data analysis with expert review to assess asset quality, pipeline viability, regulatory risks, commercial potential, and integration challenges. Our diligence reports give acquirers the confidence to make informed investment decisions.
How our m&a due diligence service delivers value to your organization.
Market sizing, competitive landscape, peak sales estimation, and commercial risk assessment for target assets.
Pipeline quality assessment, clinical trial design review, manufacturing feasibility, and technology evaluation.
Regulatory pathway assessment, compliance review, submission history analysis, and risk identification.
Post-merger integration assessment including cultural fit, operational overlap, and synergy identification.
Comprehensive deliverables that provide actionable intelligence for your team.
A structured methodology that delivers results in four phases.
Define diligence scope, key questions, and risk areas with the acquiring team.
AI-powered analysis of target data room, pipeline, clinical trials, regulatory filings, and market data.
Domain expert review of clinical, regulatory, commercial, and manufacturing findings.
Deliver comprehensive diligence report with risk assessment and investment recommendation.
A comprehensive diligence engagement typically takes 3-6 weeks depending on the complexity of the target, number of assets, and data room availability.
Yes, we provide end-to-end diligence covering commercial, technical, and regulatory dimensions.
Yes, we also support sell-side vendor diligence to prepare companies for acquisition by proactively identifying and addressing potential buyer concerns.
Target identification, deal structuring, and valuation support for in-licensing and out-licensing opportunities.
Learn moreData-driven asset valuation and portfolio optimization using clinical, commercial, and regulatory risk scoring.
Learn moreNavigate FDA, EMA, CDSCO and global regulatory pathways with real-time guidance on submissions, approvals, and compliance requirements.
Learn moreConnect with our team to discuss how our m&a due diligence service can support your goals.
Schedule a Consultation